| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Estradiol prevents oxidative stress and decreases blood
pressure in ovariectomized rats
Universidad de Murcia, Facultad de Medicina, Departamento de Fisiología y Farmacología, 30100 Murcia, Spain
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
In this study, we tested whether
estrogen deficiency is associated with oxidative stress and decreased
nitric oxide (NO) production, which could be responsible for an
increased blood pressure in ovariectomized rats. Hemodynamic studies
were performed on conscious, chronically instrumented rats. Chronic
estrogen replacement on ovariectomized rats lowered blood pressure
~13 mmHg, from 119 ± 3 mmHg in ovariectomized rats to 106 ± 3 mmHg in ovariectomized-treated rats; it was also accompanied by an increase in cardiac index and vascular conductance, achieving hemodynamic values similar to those shown by sham-operated rats. NG-nitro-L-arginine methyl ester
administration lowered significantly less the vascular conductance
(0.14 ± 0.01 vs. 0.22 ± 0.03 and 0.26 ± 0.01 ml · min
1 · mmHg1/100 g;
P < 0.05) in ovariectomized rats than in the
sham-operated and estrogen-treated ovariectomized rats, respectively.
Estrogen replacement prevented the lower plasma levels of
nitrites/nitrates observed in ovariectomized rats. The lower plasma
total antioxidant status and reduced thiol groups and the increase in
plasma lipoperoxides presented in ovariectomized animals were
reestablished with the estrogen treatment. These results show that
estrogen administration decreases blood pressure and increases vascular
conductance in ovariectomized rats. This effect may be related to an
increase in NO synthesis and/or preventing oxidative stress, then
improving endothelial function.
cardiac output; vascular conductance; nitric oxide
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
POPULATION-BASED HUMAN STUDIES showed that women have a lower prevalence of hypertension before menopause (14), leading to the hypothesis that female hormones have significant roles in the long-term regulation of peripheral resistance. It is believed that, in addition to neural and humoral mechanisms, local factors intrinsic to the wall of the vessels are important contributors to the regulation of peripheral resistance. These factors are related to the function of endothelium and arteriolar smooth muscle (18, 31). Previous studies of large isolated conduit vessels suggest that release of endothelial nitric oxide (NO) is greater in female than in male rats (15) and that ovariectomy eliminated this difference and decreased the dilation to agonists known to release NO (4, 8). Thus the protective effect of endogenous estrogen on endothelium-dependent vasodilatation in women before menopause could possibly result from a direct effect of the hormone on endothelial cells upregulating the transcription of NO synthase (9). In addition, in our previous study (4) we observed a vascular endothelium dysfunction in the aortic rings of ovariectomized rats that was reverted by addition of N-acetyl-L-cysteine, a thiol-containing compound with a free radical scavenger effect, suggesting a likely condition of oxidative stress. A further possibility is represented by the finding that estrogen can preserve endothelial function by acting as antioxidant. Several studies show that estradiol reduces lipid peroxidation in humans (33) and in hypercholesterolemic swine (16). Furthermore, Kim et al. (17) reported that estrogen protected against endothelial and myocardial dysfunction resulting from brief ischemia/reperfusion at the time that reduced superoxide anion generation after hypoxia/reperfusion. Thus these results suggest that impairment in endothelium-dependent vasodilatation in absence of estrogen could be at least partially related to the production of oxygen-derived free radicals, which inactivate NO. Hence, it is suggested that estrogen protects endothelial dysfunction through its antioxidant effect. Thus the possibility exists that an oxidative stress is present in long-term ovariectomized rats that could be related to NO-production deficiency. We also hypothesized that these disorders could be caused by endogenous estrogen deficiency. To address this issue, in the present study we examined the systemic hemodynamic and redox state in rats after 2 mo of ovariectomy and sham-operated age-control rats. The role for NO in the hemodynamic state was assessed determining nitrites/nitrates (NOx) plasma levels and hemodynamic responses to systemic application of an inhibitor of NO synthase (NG-nitro-L-arginine methyl ester). The influence of estrogen-supplementation status was determined by dividing all the ovariectomized groups into treated with pellets of estrogen and not treated animals.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Experiments were performed on female virgin and ovariectomized
Sprague-Dawley rats (250-400 g). At 12 wk of age, animals were anesthetized with Talamonal (mix of 16 mg/kg Fentanyl and 0.83 mg/kg
Droperidol), and a small abdominal incision was made with the use of a
sterile technique. Ovariectomy was performed in 28 rats, and 13 rats were exposed to sham operation. After convalescence (4 days), 13 ovariectomized rats were given a subcutaneous implant of pellets
(Innovative Research of America, Toledo, OH) containing 17
-estradiol
(1.5 mg/8 wk). The animals were cared for according to the principles
established in the Guide for the Care and Use of Laboratory
Animals.
Hemodynamic measurement.
While rats were under anesthesia, catheters were placed into the left
femoral artery for measurement of mean arterial pressure (MAP) and
heart rate (HR) and into the left femoral vein for infusion. A right
atrial catheter and a thoracic aortic thermocouple were implanted via
the right external jugular vein and right carotid artery, respectively.
The catheters were brought out through the skin on the dorsal side of
the neck. Finally, the distal ends of these lines were thread through a
lightweight flexible spring connected to a swivel. All surgical
procedures were performed under aseptic techniques. Rats were placed in
plastic cages with the swivels mounted above, allowing complete freedom
of movement and free access to chow and tap water. Three full days were
permitted for recovery from surgery. Cardiac output was measured by
thermodilution as previously described in our laboratory
(10). The thermodilution curve and the pressure signal
were processed with a microcomputer system (Cardiomax IIR, Columbus
Instruments). Hemodynamic values were the mean of three determinations.
Cardiac output was measured by rapid injection of 200 µl 0.9% saline
at room temperature (20°C) through the jugular catheter, with the use
of a spring-loaded constant-rate, constant-volume syringe (Hamilton, CR
700-200). Cardiac index (CI) was calculated by dividing cardiac
output by animal weight (100 g) and total vascular conductance (TVC) by dividing CI by MAP. Baseline hemodynamic parameters and the hemodynamic response to intravenous injections of the NO synthase inhibitor NG-nitro-L-arginine methyl ester (3 mg/kg + 50 µg · kg1 · min1 during 30 min) were evaluated in the three groups of rats, 8 wk after ovariectomy
or sham operation.
Biochemical measurements.
In another set of three different groups of rats (sham age-control,
ovariectomized, and ovariectomized + estrogen treatment), blood
samples were collected (while rats were under anesthesia) from the
carotid artery and placed in tubes containing EDTA/K3 as anticoagulant.
The samples were centrifuged to 2,500 g during 10 min at
4°C (Beckman Model TJ-6 Centrifuge; Beckman Instruments, Fullerton,
CA). The plasma was collected and immediately frozen to 
80°C until
analysis (within 30 days). Cycles of freezing-unfreezing were avoided.
To optimize the stability of the samples and to minimize the processes
of lipid peroxidation in vitro, the storage was made in tubes free of
trace elements.
SH)
groups, and the stable end products of NO (NOx).
A specific kit (Bioxytech LPO-586 Assay; Oxis International, Portland,
OR) was used to measure the plasma lipoperoxides malonaldehyde plus
(E)-4-hydroxy-2-nonenal by a colorimetric method (5) on the basis of the reaction with 1-methyl-2-phenylindole at 45°C yielding a stable chromophore with maximal absorbance at the 586-nm wavelength. Calibration solutions consisted of
1,1,3,3-tetraethoxypropane and a hydroxynonenal as diethylacetal.
Assay range was 0-20 µmol/l. Interassay coefficient of variation
was 4.7%. The light wavelength and the low temperature of incubation
used for these measurements eliminate interferences and undesirable
artifacts (5).
Plasma TAS was measured with the use of a kit supplied by Randox
Laboratories (Amtrim, UK). The assay principle is that metmyoglobin reacts with H2O2 to form the radical species
ferrylmyoglobin. A chromogen ABTS
[2,2'-Azinobis(3-ethylbenzthiazoline-sulfonic Acid)] is incubated
with the ferrylmyoglobin to produce the radical cation species
ABTS+. This has a relatively stable blue-green color, which
is measured at 600 nm. Antioxidants in the added samples cause
suppression of this color production to a degree that is proportional
to their concentration (22). The system was standardized
with the use of Trolox, a (+)-
-tocopherol analog with enhanced water
solubility. The unit of activity is the concentration (mM) of
Trolox having the equivalent antioxidant capacity to a 1.0-mM solution
of the substance under investigation. Assay range was 0-2.5 mM of
Trolox. The interassay coefficient of variation was 5%.
The SH groups present in plasma samples were determined by the Ellman
reaction (4) with DTNB [5,5'-Dithiobis-(2-nitrobenzoic Acid); Sigma]. SH groups' concentration was calculated on the basis
of a reduced glutathione (Sigma) standard curve. Assay range was
0-320 µmol/l. Interassay coefficient of variation was 4.9%.
NOx were determined by the Griess method (6);
briefly, after protein precipitation of the samples and reduction of
nitrate to nitrite with reduced NADPH in the presence of nitrate
reductase (Boehringer Mannheim; Germany), nitrite was quantified
colorimetrically at 540 nm (Nitric Oxide Colorimetric Assay; Boehringer
Mannheim). Interassay coefficient of variation was 4.8%.
Plasma level of 17-estradiol was measured by microparticle enzyme
immunoassay (IMx estradiol assay, Abbot Laboratories, North Chicago, IL).
Statistical analysis. All values are means ± SE. One-way analysis of variance for randomized measures followed by Duncan's multiple-range test was used to determine the differences in baseline hemodynamic and the effects of NG-nitro-L-arginine methyl ester and also in the biochemical determination among estrogen, sham-operated, and ovariectomized groups. Differences were considered significant at P < 0.05.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Baseline systemic hemodynamic.
Mean values for systemic hemodynamic in sham age-control
(n = 6), ovariectomized (n = 8), and
ovariectomized with estrogen replacement (n = 6) groups
are shown in Fig. 1. MAP was 13 mmHg lower in ovariectomized rats with estrogen treatment compared with that
of nontreated ovariectomized rats (~13 mmHg); from 119 ± 3 in
ovariectomized rats to 106 ± 3 mmHg in ovariectomized-treated rats (P < 0.05). This lower blood pressure was
accompanied by a 66% higher (P < 0.05) vascular
conductance and a 52% higher (P < 0.05) CI compared
with that of nontreated ovariectomized rats. In ovariectomized rats,
MAP was 119 ± 3 vs. 109 ± 5 mmHg in sham-control rats
(P < 0.05). This higher blood pressure was accompanied
by a lower level of systemic vascular conductance (0.28 ± 0.02 vs. 0.40 ± 0.04 ml · min1 · mmHg1/100 g)
and lower CI compared with that of the age-control group (33.52 ± 1.54 vs. 42.41 ± 3.10 ml · min1 · 100 g1). As
presented in Fig. 1, ovariectomized animals with estrogen treatment
show hemodynamic values similar to sham-operated rats. There was no
difference in the baseline HR among the three groups of rats. Body
weight after 8 wk of sham, ovariectomy, and ovariectomy plus estrogen
replacement was 283 ± 13, 391 ± 16, and 280 ± 7 g, respectively.
|
Hemodynamic response to NO synthase inhibition.
Administration of
NG-nitro-L-arginine methyl ester to
sham-operated and ovariectomized rats elicited a rise in MAP to an
average of 145 ± 6 and 153 ± 11 mmHg, respectively, 30 min
after its injection. Estrogen-replacement therapy did not modify the
pressor response produced by inhibition of NO synthase in
ovariectomized rats (Fig. 2).
|
12.3 ± 1.5 ml · min1 · 100 g1)
produced by NG-nitro-L-arginine
methyl ester in ovariectomized rats was less than that determined in
sham-operated rats (16.6 ± 3.5 ml · min1 · 100 g1), these
differences were not statistically significant. The decrease in CI was
more pronounced in the ovariectomized estrogen-replaced group compared
with that of the ovariectomized rats. Although the increase in MAP
produced by NG-nitro-L-arginine
methyl ester was of similar magnitude in ovariectomized rats, the
decrease in vascular conductance (0.14 ± 0.01 ml · min1 · mmHg1/100 g)
was lower than that recorded in sham-operated animals (0.22 ± 0.03 ml · min1 · mmHg1/100
g, P < 0.05). Furthermore, estrogen-replacement
therapy restored the response in vascular conductance produced by
inhibition of NO synthase, achieving a higher (0.26 ± 0.1, P < 0.05) decrease in ovariectomized estrogen-replaced
rats compared with ovariectomized animals.
Biochemical measurements.
Compared with the sham-operated (n = 7) group,
ovariectomy (n = 7) induced a significant increase in
plasma lipoperoxides that was accompanied by a lower TAS and a lower
plasma level of SH groups (Fig. 3).
Estrogen-replacement therapy (n = 7) induced a
significant increase in plasma TAS and SH groups that was associated with a decrease in plasma lipoperoxides concentration; these parameters returned to values similar to those of sham-operated animals. Furthermore, the stable end products of NO NOx were
significantly lower in ovariectomized animals compared with those of
sham-operated rats (Fig. 3). Again, estrogen therapy significantly
increased NOx to a level similar to that observed in
sham-operated animals.
|
-estradiol concentration was (in pg/ml) 97.4 ± 4.3 in
sham-operated, 6.9 ± 0.4 in ovariectomized, and 164.6 ± 4.2 in ovariectomized estrogen-replaced rats.
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
This study shows that estrogen plays a significant role in modulating the blood pressure of female rats. Our results showed that treatment with estrogen decreased baseline blood pressure compared with ovariectomized animals. These data agree with accumulating evidence of a link between increased prevalence of hypertension and postmenopausal stages in women (29). Our results are further complemented by recent studies showing that transdermal estrogen exerts beneficial effects, both in lowering elevated blood pressure and in maintaining a uniform blood pressure control over 24 h (22). In addition, Brosnihan et al. (2) showed that both ovariectomized Sprague-Dawley normotensive and transgenic hypertensive rats (mouse Ren-2 gene) treated with estrogen for 4 wk presented significantly lower blood pressure levels than nontreated animals, suggesting a beneficent effect of estrogen on cardiovascular control system. On the other hand, this is one of the first studies that shows an elevation in blood pressure in normotensive rats after ovariectomy. Recently, Milsted et al. (23) have reported an increase in systolic blood pressure in female Wistar-Kyoto rats after 7 wk after ovariectomy. However, other studies have reported no increase in blood pressure after ovariectomy. Nickenig et al. (24) reported no significant differences in blood pressure between ovariectomized or sham-operated Wistar-Kyoto rats. These discrepancies may be explained by the different times after ovariectomy. Nickenig et al. (24) reported that rats were killed 5 wk after ovariectomy, instead 8 wk were allowed after ovariectomy in the present work.
In our study, ovariectomy significantly decreased CI and TVC of female rats, and estrogen replacement prevented this hemodynamic disorder. This result is in agreement with those of Huang et al. (12) reporting that ovariectomy decreased the basal tone of arterioles of female rats, and estrogen replacement restored the myogenic tone of arterioles to a level identical to that of normal female rats. These results suggest that the chronic absence of circulating estrogen may well be responsible for the observed differences in basal TVC in our ovariectomized rats. Our data are further supported by a recent study in postmenopausal women showing that transdermal estradiol treatment significantly increased cardiac output and stroke volume that were accompanied by a decrease in blood pressure (1).
In the present study, ovariectomy reduced plasma levels of NO
metabolites, nitrites and nitrates. Furthermore, as other previous studies in postmenopausal women show (27), 17-estradiol
administration increased the circulating levels of nitrites and
nitrates in ovariectomized rats. Our findings are supported by our
previous results (4) and of Hayashi et al.
(8) where basal release of NO from the aortic rings of
ovariectomized rats and rabbits was lower than their respective female
control animals. In addition, other studies in vitro showed that
endothelial nitric oxide synthase increases in response to
17-estradiol in human (11), bovine aortic endothelial cells (9), and ovine fetal pulmonary artery endothelial
cells (21). Therefore, it was logical to assume
that a greater release of NO, due to the presence of estrogen, may
be responsible for the difference in basal TVC between
ovariectomized and both sham-operated and ovariectomized
estrogen-treated rats.
NG-nitro-L-arginine methyl ester administration elicited a similar hemodynamic effect in the ovariectomized group as that previously published by our laboratory (10) in Sprague-Dawley rats. In addition, although there was no difference in the magnitude of the pressor response elicited by NG-nitro-L-arginine methyl ester among the three groups, the decrease in vascular conductance was significantly greater in normal female and ovariectomized estrogen-treated rats than in ovariectomized rats. These data suggest that the significant reduction in basal vascular conductance that was found in ovariectomized rats may reflect a minor dependence of vascular conductance on NO in this group.
Then, we speculate that the physiological importance of our findings is that the greater release of NO in the vasculature of normal and ovariectomized rats with estrogen replacement tends to increase peripheral vascular conductance by eliciting a greater suppression of the constrictor mechanisms compared with what occurs in ovariectomized rats. That mechanism may be responsible for the lower blood pressure present in animals with estrogen in the current study. Indeed, previous studies showed that estrogen augments the contribution of NO to regulate blood pressure in transgenic hypertensive rats expressing the mouse Ren-2 gene (2) and that estrogen attenuates the development of hypertension in spontaneously hypertensive rats (35). Even though changes in blood pressure in response to NG-nitro-L-arginine methyl ester infusion were not different among the three groups of rats, a higher HR response was seen in the ovariectomized rats. This contradictory blood pressure and HR response to NG-nitro-L-arginine methyl ester is difficult to explain. However, a possible explanation may be a difference in baroreflex sensitivity among ovariectomized rats and the other two groups that have estrogen. Recently, it has been reported that lower tolerance to lower body negative pressure in females was associated with reduced HR response to carotid baroreceptor stimulation compared with men (3).
In the present study, we also show that ovariectomy induces alterations
in the redox state, characterized by decreased plasma TAS and SH
groups and an increase in plasma lipoperoxides. These plasma data may
reflect an unbalance in the redox state toward oxidative process that
may be associated with a decrease in NO activity. On the other hand,
several studies report that bioactivity of NO is closely related to
S-nitrosothiols compounds that appear to be more potent smooth muscle
relaxants than NO itself (13, 30). Various
vascular related disorders, including coronary artery disease, stroke,
hypertension, and shock, are thought to be mediated at least in part
through changes in the general redox state and thiol content of
vascular tissue. Indeed, there is evidence for an oxidative stress in
young essential hypertensive patients and spontaneously hypertensive
rats (25, 32). Furthermore, hypertension has been
associated with an endothelial dysfunction (19, 20). In
addition, N-acetyl-L-cysteine increases the
antihypertensive response to captopril and enalaprilat in SHR by a
NO-dependent mechanism (28), suggesting that an
equilibrium exists between NO and S-nitrosothiol in a biological system
that may be influenced by redox state. Furthermore, our results showing
an alteration of redox state and decrease in NOx levels are
further supported by previous studies from our laboratory. These
studies showed that N-acetyl-L-cysteine, a
thiol-containing compound, reverted vascular endothelium dysfunction
present in aortic rings from ovariectomized rats (4).
These results suggest that an alteration in endogenous free radical
production under a condition of oxidative stress in ovariectomized rats
may play an important role in modulating spontaneous and
agonist-stimulated NO production and thus in altering vascular
function. In addition, in the present study, estrogen-replacement therapy induced a significant increase in plasma TAS and SH groups that was associated with a decrease in plasma lipoperoxides
concentration; these parameters returned to values similar to those
obtained from sham-operated animals. Furthermore, ovariectomized rats
treated with estrogen presented higher plasma levels of NOx
and a bigger response in vascular conductance to NO inhibition. To
explain these results, a possibility is represented by the finding that estrogen can preserve endothelial function by acting as antioxidant. Several studies have shown that 17-estradiol reduces lipid
peroxidation in plasma and platelet membranes from postmenopausal women
(33, 34). Furthermore, Kim et al. (17)
reported that estrogen protects against endothelial and myocardial
dysfunction resulting from brief ischemia/reperfusion. This effect was
associated with increased serum NOx concentration and
reduced superoxide anion generation in arterial segments after
hypoxia/reperfusion. These results suggest that impairment in
endothelium-dependent vasodilatation in absence of estrogen could be at
least partly related to the production of oxygen-derived free radicals,
which inactivate NO. It is also suggested that estrogen protects
endothelial dysfunction through its antioxidant effect. However,
estrogen has been shown to increase endothelial NO synthase protein and
mRNA (21). Therefore, after ovariectomy, NO synthase may
be reduced, which is in agreement with the plasma NOx
levels reported in the present manuscript. Therefore, the effects of
estrogen on blood pressure may be mediated both by altering endothelial
NO synthase expression and its antioxidant effects.
In summary, our data indicate that estrogen deprivation induced an alteration in redox state that may be responsible for the decreased release of NO and therefore the decrease in systemic vascular conductance that is reflected by a higher blood pressure. Furthermore, estrogen treatment to ovariectomized rats decreases blood pressure, and this effect may be mediated both by altering endothelial NO synthase expression and its antioxidant effect.
Perspectives
The results of the present study and others support the hypothesis that the availability ofSH groups may be an important modulating
factor in the expression of the endothelium-derived NO effect, hence of
vascular tone. Thus it may be speculated that situations where oxidant
stress may decrease the capability of the antioxidant mechanisms could
cause an impairment of action of NO on vascular network beds. Our
results show an association of oxidative stress and deficiency of
estrogens that is prevented by replacement therapy. The
pathophysiological significance of this interaction among estrogens,
redox state, and NO could be of interest in preventing the major
prevalence in vascular abnormalities conducing hypertension and
atherosclerosis present in postmenopause.
| |
ACKNOWLEDGEMENTS |
|---|
This investigation was supported by Dirección General de Investigación Científica y Técnia Grant from el Ministerio de Educación y Ciencia, PB94-1150 and FISS-98/0606.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: I. H. Garcia, Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Murcia, Campus de Espinardo, 30100 Murcia, Spain (E-mail: isabelhg{at}um.es).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 2 December 1999; accepted in final form 10 July 2000.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Alfie, J,
Lugones L,
Belardo A,
Tutzer M,
Galarza CR,
Waisman GD,
and
Camera MI.
Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate.
Maturitas
27:
163-169,
1997[ISI][Medline].
2.
Brosnihan, BK,
Moriguchi A,
Nakamoto H,
Dean RH,
Ganten D,
and
Ferrario C.
Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene.
Am J Hypertens
7:
576-582,
1994[ISI][Medline].
3.
Convertino, VA.
Gender differences in autonomic functions associated with blood pressure regulation.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1909-R1920,
1998
4.
Delgado, JL,
Landeras J,
Carbonell LF,
Parrilla JJ,
Abad L,
Quesada T,
Fiol G,
and
Hernandez I.
Effect of N-Acetylcysteine on vascular endothelium function in aorta from oophorectomized rats.
Gen Pharmacol
32:
23-27,
1998.
5.
Ellman, GL.
Tissue sulfhydryl groups.
Arch Biochem Biophys
82:
70-77,
1959[ISI][Medline].
6.
Essterbauer, H,
and
Cheeseman KH.
Determination of aldehidic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal.
Methods Enzymol
186:
407-421,
1990[Medline].
7.
Green, LC,
Warner DA,
Glogowski J,
Skinner PL,
Wishnok JS,
and
Tannenbaum SR.
Analysis of nitrate nitrite and 15N-nitrate in biological fluids.
Anal Biochem
126:
131-138,
1982[ISI][Medline].
8.
Hayashi, T,
Fukutto JM,
Ignarro LJ,
and
Chaudhuri G.
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implication for atherosclerosis.
Proc Natl Acad Sci USA
89:
11259-11263,
1992
9.
Hayashi, T,
Yamada K,
Esaki T,
Kuzuya M,
Satke S,
Ishikawa T,
Hidaka H,
and
Iguchi A.
Estrogen increases endothelial nitric oxide by a receptor-mediated system.
Biochem Biophys Res Commun
214:
847-855,
1995[ISI][Medline].
10.
Hernández, I,
Delgado JL,
Carbonell LF,
Pérez MC,
and
Quesada T.
Hemodynamic effects of 17-estradiol in absence of NO in ovariectomized rats: role of angiotensin II.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R970-R978,
1998
11.
Hishikawa, K,
Nakaki T,
Marumo T,
Suzuki H,
Kato R,
and
Saruta T.
Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells.
FEBS Lett
360:
291-293,
1995[ISI][Medline].
12.
Huang, A,
Sun D,
Koller A,
and
Kaley G.
Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO.
Am J Physiol Heart Circ Physiol
272:
H1804-H1809,
1997
13.
Ignarro, LJ,
Lippton H,
Edwards JC,
Baricos WH,
Hyman AL,
Kadowitz PJ,
and
Grueter CA.
Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
J Pharmacol Exp Ther
218:
739-749,
1981
14.
Isles, CG,
Hole DJ,
Hawthorne VM,
and
Lever AF.
Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men.
Lancet
339:
702-706,
1992[ISI][Medline].
15.
Kauser, K,
and
Rubanyi GM.
Gender difference in bioassayable endothelium-derived NO from isolated rat aortas.
Am J Physiol Heart Circ Physiol
267:
H2311-H2317,
1994
16.
Keaney, JF,
Shwaery GT,
Xu A,
Nicolosi RJ,
Loscalzo J,
Foxall TL,
and
Vita JA.
17 -Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine.
Circulation
89:
2251-2259,
1994
17.
Kim, YD,
Chen B,
Beauregard J,
Kouretas P,
Thomas G,
Farhat MY,
Myers AK,
and
Lees DE.
17 beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion.
Circulation
94:
2901-2908,
1996
18.
Koller, A,
Sun D,
Huang A,
and
Kaley G.
Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles.
Am J Physiol Heart Circ Physiol
267:
H326-H332,
1994
19.
Linder L, Kiowski W, Bühler FR, and Lücher TF.
Indirect evidence for the release of endothelium-derived relaxing
factor in human forearm circulation in vivo: blunted response in
essential hypertension. Circulation 81: 1762-1767.
20.
Lücher, TF,
Dohi Y,
and
Tschudi M.
Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension.
J Cardiovasc Pharmacol
19, Suppl 5:
S34-S42,
1992.
21.
MacRitchie, AN,
Jun SS,
Chen Z,
German Z,
Yuhanna IS,
Sherman TS,
and
Shaul PW.
Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium.
Circ Res
81:
355-362,
1997
22.
Mercuro, G,
Zoncu S,
Pilia I,
Lao A,
Melis GB,
and
Cherchi A.
Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension.
Am J Cardiol
80:
652-655,
1997[ISI][Medline].
23.
Milsted, A,
Marcelo MC,
Turner ME,
and
Ely DL.
Female Wistar-Kyoto and SHR/y rats have the same genotype but different patterns of expression of renin and angiotensinogen genes.
J Hypertens
16:
823-828,
1998[ISI][Medline].
24.
Nickenig, G,
Bäumer AT,
Grohé C,
Kahlert S,
Strehlow K,
Rosenkranz S,
Stäblein A,
Beckers F,
Smits J,
Daemen M,
Vetter H,
and
Böhm M.
Estrogen modulates AT1 receptor gene expression in vitro and in vivo.
Circulation
97:
2197-2201,
1998
25.
Parik, T,
Allikments K,
Teesalu R,
and
Zilmer M.
Evidence for oxidative stress in essential hypertension: perspective for antioxidant therapy.
J Cardiovasc Risk
3:
49-54,
1996[Medline].
26.
Rice-Evans, C,
and
Miller NJ.
Total antioxidant status in plasma and body fluids.
Methods Enzymol
234:
279-293,
1993.
27.
Rosselli, M,
Imthurn B,
Keller PJ,
Jackson EK,
and
Dubey RK.
Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.
Hypertension
25:
848-853,
1995
28.
Ruiz, FJ,
Salom MG,
Ingles AC,
Quesada T,
Vicente E,
and
Carbonell LF.
N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
Am J Physiol Regulatory Integrative Comp Physiol
267:
R767-R772,
1994
29.
Sitruk-Ware, R,
and
Ibarra de Palacios P.
Oestrogen replacement therapy and cardiovascular disease in postmenopausal women.
Maturitas
11:
259-274,
1989[ISI][Medline].
30.
Stamler, JS,
Jaraki O,
Osvorne J,
Simon DI,
Keaney J,
Vita J,
Singel D,
Valeri CR,
and
Loscalzo J.
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Proc Natl Acad Sci USA
89:
7674-7677,
1992
31.
Sun, D,
Huang A,
Koller A,
and
Kaley G.
Flow-dependent dilation and myogenic constriction interact to establish the resistance of skeletal muscle arterioles.
Microcirculation
2:
289-295,
1995[Medline].
32.
Suzuki, H,
Swei A,
Zweifach BW,
and
Schmid Schonbein GW.
In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography.
Hypertension
25:
1083-1089,
1995
33.
Tang, M,
Abplanalp W,
Ayres S,
and
Subbiah MT.
Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation.
Metabolism
45:
411-414,
1996[ISI][Medline].
34.
Tranquilli, AL,
Mazzanti L,
Cugini AM,
Cester N,
Garzetti GC,
and
Romanini C.
Transdermal estradiol and medroxiprogesterone acetate in hormone replacement therapy are both antioxidants.
Gynecol Endocrinol
9:
137-141,
1995[ISI][Medline].
35.
Williams, SP,
Shakelford DP,
Iams SG,
and
Mustafa J.
Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats.
Eur J Pharmacol
145:
205-207,
1988[ISI][Medline].
This article has been cited by other articles:
|
|
 |
|
  T. Ebrahimian, M. R. Sairam, E. L. Schiffrin, and R. M. Touyz Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1481 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yaras, E. Tuncay, N. Purali, B. Sahinoglu, G. Vassort, and B. Turan Sex-related effects on diabetes-induced alterations in calcium release in the rat heart Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3584 - H3592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Sullivan, L. Semprun-Prieto, E. I. Boesen, D. M. Pollock, and J. S. Pollock Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1573 - R1579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pincemail, S. Vanbelle, U. Gaspard, G. Collette, J. Haleng, J.P. Cheramy-Bien, C. Charlier, J.P. Chapelle, D. Giet, A. Albert, et al. Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium Hum. Reprod., August 1, 2007; 22(8): 2335 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sullivan, J. M. Sasser, and J. S. Pollock Sexual dimorphism in oxidant status in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R764 - R768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gimenez, M. P. Garcia, M. Serna, B. Bonacasa, L. F. Carbonell, T. Quesada, and I. Hernandez 17{beta}-Oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats Exp Physiol, July 1, 2006; 91(4): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Moreau, K. M. Gavin, A. E. Plum, and D. R. Seals Ascorbic Acid Selectively Improves Large Elastic Artery Compliance in Postmenopausal Women Hypertension, June 1, 2005; 45(6): 1107 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Xue, J. Pamidimukkala, and M. Hay Sex differences in the development of angiotensin II-induced hypertension in conscious mice Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2177 - H2184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xu, S. J. Armstrong, I. A. Arenas, D. J. Pehowich, and S. T. Davidge Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H165 - H171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Orshal and R. A. Khalil Gender, sex hormones, and vascular tone Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R233 - R249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Javeshghani, R. M. Touyz, M. R. Sairam, A. Virdis, M. F. Neves, and E. L. Schiffrin Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a Model of Menopause-Associated Hypertension Hypertension, October 1, 2003; 42(4): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. F. Ba, J. F. Kuebler, L. W. Rue III, K. I. Bland, P. Wang, and I. H. Chaudry Gender dimorphic tissue perfusion response after acute hemorrhage and resuscitation: role of vascular endothelial cell function Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2162 - H2169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Armstrong, Y. Zhang, K. G. Stewart, and S. T. Davidge Estrogen replacement reduces PGHS-2-dependent vasoconstriction in the aged rat Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H893 - H898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. N. Das Nitric Oxide as the Mediator of the Antiosteoporotic Actions of Estrogen, Statins, and Essential Fatty Acids Experimental Biology and Medicine, February 1, 2002; 227(2): 88 - 93. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
P < 0.05 vs. Ovx.
